A perspective on a precision approach to pain in cancer; moving beyond opioid therapy.
expert_opinion · Level V
Where this comes from
- Record sourced from PubMed, PMID 37194659.
- Also identified by DOI 10.1080/09638288.2023.2212916.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Cancer-related pain is primarily treated with opioids which while effective can add significant patient burden due to side effects, associated stigma, and timely access. The purpose of this perspective discussion is to argue for a precision approach to pain in cancer based on a biopsychosocial and spiritual model which we argue can offer a higher quality of life while limiting opioid use. Pain in cancer represents a heterogenous process with multiple contributing and modulating factors. Specific characterization of pain as either nociceptive, neuropathic, nociplastic, or mixed can allow for targeted treatments. Additional assessment of biopsychosocial and spiritual issues can elucidate further points of targeted intervention which can lead to overall greater pain control.
Medical subject headings
- Analgesics, Opioid
- Cancer Pain
- Pain Management
- Quality of Life